Recombinant proteins of spike protein of SARS-CoV-2 with the Omicron receptor-binding domain induce production of highly Omicron-specific neutralizing antibodies

Various vaccines have been developed to fight severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for the coronavirus disease 2019 pandemic. However, new variants of SARS-CoV-2 undermine the effort to fight SARS-CoV-2. Here, we produced S proteins harboring the recept...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Hyangju, Kim, Daniel, Min, Kyungmin, Park, Minhee, Kim, Seok-Hyun, Sohn, Eun-Ju, Choi, Bo-Hwa, Hwang, Inhwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Vaccine Society 2022
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691866/
https://www.ncbi.nlm.nih.gov/pubmed/36451664
http://dx.doi.org/10.7774/cevr.2022.11.3.285

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691866/
https://www.ncbi.nlm.nih.gov/pubmed/36451664
http://dx.doi.org/10.7774/cevr.2022.11.3.285

Ejemplares similares